Sarissa Capital Catapult Fund Llc - Net Worth and Insider Trading

Sarissa Capital Catapult Fund Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sarissa Capital Catapult Fund Llc owns 2 companies in total, including Regulus Therapeutics Inc (RGLS) , and Iterum Therapeutics PLC (ITRM) .

Click here to see the complete history of Sarissa Capital Catapult Fund Llc’s form 4 insider trades.

Insider Ownership Summary of Sarissa Capital Catapult Fund Llc

Ticker	Comapny	Transaction Date	Type of Owner
RGLS	Regulus Therapeutics Inc	2019-05-07	10 percent owner
ITRM	Iterum Therapeutics PLC	2021-02-11	10 percent owner

Sarissa Capital Catapult Fund Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sarissa Capital Catapult Fund Llc Ownership Network

Ownership Network List of Sarissa Capital Catapult Fund Llc

No Data

Ownership Network Relation of Sarissa Capital Catapult Fund Llc

Sarissa Capital Catapult Fund Llc Owned Company Details

What does Regulus Therapeutics Inc do?

Who are the key executives at Regulus Therapeutics Inc?

Sarissa Capital Catapult Fund Llc is the 10 percent owner of Regulus Therapeutics Inc. Other key executives at Regulus Therapeutics Inc include Chief Financial Officer Crispina Calsada , Sr. VP & General Counsel Christopher Ray Aker , and Chief Operating Officer Joseph P Hagan .

Regulus Therapeutics Inc (RGLS) Insider Trades Summary

Over the past 18 months, Sarissa Capital Catapult Fund Llc made no insider transaction in Regulus Therapeutics Inc (RGLS). Other recent insider transactions involving Regulus Therapeutics Inc (RGLS) include a net sale of 14,580 shares made by Joseph P Hagan , a net sale of 5,468 shares made by Christopher Ray Aker , and a net sale of 5,468 shares made by Crispina Calsada .

In summary, during the past 3 months, insiders sold 0 shares of Regulus Therapeutics Inc (RGLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,516 shares of Regulus Therapeutics Inc (RGLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 25,516 shares.

Regulus Therapeutics Inc (RGLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Regulus Therapeutics Inc Insider Transactions

No Available Data

Sarissa Capital Catapult Fund Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Sarissa Capital Catapult Fund Llc. You might contact Sarissa Capital Catapult Fund Llc via mailing address: 660 Steamboat Road, 3rd Floor, Greenwich Ct 06830.

Discussions on Sarissa Capital Catapult Fund Llc

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.